An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy
Clinical trial NCT02090959 · TERMINATED
Trial details
- NCT number
- NCT02090959
- Sponsor
- PTC Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-20
- Primary completion
- 2018-06-12
- Enrollment
- 219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.